av/marksans-pharma--big.svg

COM:MARKSANSPHARMA

Marksans Pharma

  • Stock

Last Close

305.35

21/11 10:00

Market Cap

87.17B

Beta: -

Volume Today

1.94M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
6.30B
-
7.97B
26.46%
8.93B
12.13%
7.67B
14.12%
9.13B
18.97%
9.87B
8.18%
9.87B
0%
13.68B
38.59%
14.80B
8.17%
14.80B
0%
21.77B
47.11%
cost of revenue
3.68B
-
4.45B
21.07%
5.10B
14.43%
4.72B
7.39%
5.48B
16.14%
5.17B
5.60%
5.17B
0%
6.19B
19.54%
7.48B
20.92%
7.48B
0%
14.06B
87.97%
gross profit
2.62B
-
3.51B
34.03%
3.84B
9.22%
2.95B
23.07%
3.65B
23.50%
4.70B
28.90%
4.70B
0%
7.50B
59.58%
7.32B
2.36%
7.32B
0%
7.71B
5.36%
selling and marketing expenses
99.13M
-
236.78M
138.86%
475.90M
100.98%
666.31M
40.01%
666.31M
0%
1.10B
64.51%
1.49B
36.35%
1.49B
0%
general and administrative expenses
214.54M
-
192.03M
10.49%
206.30M
7.43%
232.05M
12.48%
232.05M
0%
238.83M
2.92%
247.99M
3.84%
247.99M
0%
selling general and administrative expenses
313.67M
-
428.82M
36.71%
682.20M
59.09%
898.35M
31.69%
898.35M
0%
1.33B
48.60%
1.74B
30.53%
1.74B
0%
3.87B
122.13%
research and development expenses
57.13M
-
128.66M
-
192.50M
49.62%
other expenses
1.60B
-
1.83B
14.16%
2.48B
35.80%
2.50B
0.75%
1.99M
99.92%
903.63K
54.65%
903.63K
0%
38.73M
4,186.44%
95.62M
146.87%
3.41B
3,467.49%
504.22M
85.22%
cost and expenses
5.28B
-
6.28B
18.97%
7.89B
25.64%
7.65B
3.08%
8.61B
12.60%
8.78B
1.96%
8.78B
0%
10.50B
19.55%
12.63B
20.36%
12.63B
0%
17.93B
41.93%
operating expenses
1.60B
-
1.83B
14.16%
2.79B
52.98%
2.93B
4.79%
3.13B
6.90%
3.61B
15.21%
3.61B
0%
4.31B
19.57%
5.15B
19.56%
5.15B
0%
3.87B
24.90%
interest expense
86.98M
-
62.94M
27.64%
39.61M
37.07%
64.94M
63.93%
59.25M
8.76%
59.25M
0%
34.68M
41.47%
53.90M
55.44%
53.90M
0%
112.03M
107.85%
ebitda
1.18B
-
1.81B
53.39%
1.41B
21.83%
495.59M
64.92%
831.35M
67.75%
1.33B
59.76%
1.33B
0%
3.54B
166.85%
2.95B
16.88%
2.95B
0%
4.59B
55.68%
operating income
864.11M
-
1.56B
80.40%
1.07B
31.46%
155.29M
85.47%
515.99M
232.27%
1.09B
111.89%
1.09B
0%
3.09B
182.82%
2.14B
30.76%
2.50B
16.67%
3.84B
53.85%
depreciation and amortization
156.91M
-
161.34M
2.82%
281.27M
74.33%
300.93M
6.99%
268.38M
10.82%
228.04M
15.03%
228.04M
0%
361.51M
58.53%
447.76M
23.86%
447.76M
0%
167.90K
99.96%
total other income expenses net
-157.09M
-
-127.69M
18.72%
25.56M
120.02%
131.04M
412.71%
-18.01M
113.74%
-50.28M
179.23%
-50.28M
0%
-70.56M
40.33%
334.07M
573.46%
-22.83M
106.83%
392.19M
1,817.87%
income before tax
864.11M
-
1.56B
80.40%
1.07B
31.46%
155.29M
85.47%
497.98M
220.67%
1.04B
109.46%
1.04B
0%
3.02B
189.69%
2.48B
18.09%
2.48B
0%
4.24B
71.11%
income tax expense
127.87M
-
439.21M
243.48%
241.08M
45.11%
35.15M
85.42%
139.97M
298.22%
238.69M
70.53%
238.69M
0%
636.25M
166.55%
606.97M
4.60%
606.97M
0%
1.09B
78.97%
net income
719.08M
-
1.09B
52.13%
785.12M
28.23%
95.19M
87.88%
329.40M
246.05%
804.37M
144.19%
804.37M
0%
2.39B
196.55%
1.87B
21.68%
1.87B
0%
3.14B
67.92%
weighted average shs out
385.31M
-
409.31M
6.23%
409.31M
0%
409.31M
0%
409.31M
0%
409.31M
0%
409.31M
0%
409.31M
0.00%
414.22M
1.20%
409.31M
1.19%
453.32M
10.75%
weighted average shs out dil
385.31M
-
409.31M
6.23%
409.31M
0%
409.31M
0%
409.31M
0%
409.31M
0%
409.31M
0%
409.31M
0.00%
414.22M
1.20%
409.31M
1.19%
453.32M
10.75%
eps
1.87
-
2.67
42.78%
1.92
28.09%
0.22
88.54%
0.80
263.64%
1.97
146.25%
1.97
0%
5.76
192.39%
4.51
21.70%
4.56
1.11%
6.92
51.75%
epsdiluted
1.87
-
2.67
42.78%
1.92
28.09%
0.22
88.54%
0.80
263.64%
1.97
146.25%
1.97
0%
5.76
192.39%
4.51
21.70%
4.56
1.11%
6.92
51.75%

All numbers in (except ratios and percentages)